Abstract 17942: Oxidative Stress and Apolipoprotein E3 in Brain Endothelial Cells

    loading  Checking for direct PDF access through Ovid


Introduction: Apolipoprotein E3 (apoE3) is an exchangeable protein that plays a significant role as an anti-atherogenic apolipoprotein. It serves as a ligand for the LDL receptor (LDLr) family of proteins that mediate cellular uptake of lipoproteins and plays a significant role in regulating plasma cholesterol homeostasis. In this study, we investigate the functional consequences of acrolein-mediated oxidative damage to human apoE3 in brain endothelial cells that are the primary constituents of the blood brain barrier. Acrolein is an α,β-unsaturated aldehyde that is an environmental pollutant and is also generated endogenously as bye-products of lipid peroxidation. It is considered an oxidative stress reagent that causes oxidative damage to cellular components, including proteins.

Hypothesis: We test the hypothesis that acrolein modification impairs the structural integrity and functional ability of apoE3.

Methods: Recombinant human apoE3 was modified with varying concentrations of acrolein, and the modification confirmed by Western Blot analysis using acrolein-Lys-specific antibodies. Modified apoE3 was reconstituted with POPC and the resultant reconstituted HDL (rHDL) was isolated by density gradient ultracentrifugation.

Results: We note that rHDL bearing acrolein-modified apoE3 does not interact with soluble LDLr in co-immunoprecipitation assays suggesting oxidative modification of essential Lys residues required for interaction with the ligand-binding domain of the LDLr. However, incubation with mouse brain cerebral cortex endothelial cells, showed internalization of acrolein-modified apoE3. Incubation with suramin, an inhibitor of the LDLr, does not abolish cellular uptake of acrolein-modified apoE3, suggesting alternative uptake pathways likely involving the scavenger receptor family of proteins. Incubation with LOX1 antibody showed a decrease in cellular uptake of acrolein-modified apoE3.

Conclusion: Taken together, this study defines acrolein-modified apoE3 as a hitherto unidentified ligand for scavenger receptors. It offers insight into the molecular basis of oxidative stress mediated damage to apolipoproteins and their role in pathogenesis of cardiovascular and cerebrovascular diseases.

Related Topics

    loading  Loading Related Articles